Ann Arbor, Michigan
Colorectal cancer clinical trials in Ann Arbor, MI
29 colorectal cancer studies are recruiting participants at sites in Ann Arbor as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Ann Arbor at a glance
- 29 studies are recruiting at a site in Ann Arbor.
- By phase: Phase 1 (4), Phase 1/2 (4), Phase 2 (3), Phase 2/3 (1), Phase 3 (7), No phase (5), Observational (5). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (15), industry (13), government (1).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Ann Arbor
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study site
- University of Michigan Rogel Cancer Center
- Registry record
- NCT05863195 · updated
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Vividion Therapeutics, Inc.
- Study site
- University of Michigan
- Registry record
- NCT06004245 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- University of Michigan
- Registry record
- NCT07020221 · updated
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Trinity Health IHA - Obstetrics and Gynecology West Arbor · Trinity Health Saint Joseph Mercy Hospital Ann Arbor
- Registry record
- NCT07018869 · updated
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
- Observational
- Ages 60 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
- Registry record
- NCT03998202 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor · University of Michigan Rogel Cancer Center
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
- Registry record
- NCT06418204 · updated
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Trinity Health IHA - Obstetrics and Gynecology West Arbor · Trinity Health Saint Joseph Mercy Hospital Ann Arbor
- Registry record
- NCT07283939 · updated
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- University of Michigan Health System
- Registry record
- NCT05379595 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
- Registry record
- NCT05673148 · updated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study sites
- University of Michigan · VA Ann Arbor Healthcare System
- Registry record
- NCT06662786 · updated
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- University of Michigan Rogel Cancer Center
- Registry record
- NCT06750094 · updated
Family Communications After Genetic Testing
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
- Registry record
- NCT07143487 · updated
FITting Non-invasive Tests in Lynch Syndrome Surveillance
- No phase
- Ages 20 to 80
- All sexes
- Sponsor
- University of Chicago
- Study site
- University of Michigan
- Registry record
- NCT06898996 · updated
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Trinity Health St Joseph Mercy Ann Arbor
- Registry record
- NCT07284849 · updated
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- University Of Michigan /ID# 270790
- Registry record
- NCT06820463 · updated
The Cancer of the Pancreas Screening-5 CAPS5)Study
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- University of Michigan
- Registry record
- NCT02000089 · updated
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- University of Michigan Rogel Cancer Center
- Registry record
- NCT05630794 · updated
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- University of Michigan Health System - Ann Arbor /ID# 273511
- Registry record
- NCT07023289 · updated
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- No phase
- Ages 65 to 82
- All sexes
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study site
- University of Michigan Health
- Registry record
- NCT05612347 · updated
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- University of Michigan
- Registry record
- NCT06253871 · updated
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Phase 1
- Ages 12 to 85
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Study site
- University of Michigan
- Registry record
- NCT03715933 · updated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Phase 1/2
- From 12 months, up to 30 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- C S Mott Children's Hospital
- Registry record
- NCT04851119 · updated
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Rapamycin Holdings Inc.
- Study site
- University of Michigan
- Registry record
- NCT06950385 · updated
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of Michigan Rogel Cancer Center
- Study site
- University of Michigan Rogel Cancer Center
- Registry record
- NCT06641310 · updated
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- University of Michigan Rogel Cancer Center
- Study site
- University of Michigan
- Registry record
- NCT00843375 · updated
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Observational
- All ages
- All sexes
- Sponsor
- Massive Bio, Inc.
- Study site
- Massive Bio SYNERGY-AI site
- Registry record
- NCT03452774 · updated
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- LigaChem Biosciences, Inc.
- Study site
- University of Michigan
- Registry record
- NCT05941507 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Ann Arbor, MI on ClinicalTrials.gov.
Ask about studies near Ann Arbor
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Michigan
All Michigan locations
91 studies recruiting across 58 cities.
Grand Rapids
50 studies recruiting.
Detroit
35 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections